ICD-10 Coding for Lymphoma(C83.3, C83.3A)
Complete ICD-10-CM coding and documentation guide for Lymphoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Lymphoma
C81-C88Primary Range
Malignant neoplasms of lymphoid, hematopoietic and related tissue
This range includes all primary lymphoma codes, covering various types and stages of lymphoma.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C83.3 | Diffuse large B-cell lymphoma | Use when DLBCL is confirmed by pathology and is active. |
|
| C83.3A | Diffuse large B-cell lymphoma, in remission | Use when DLBCL is in remission as confirmed by imaging. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for lymphoma
Essential facts and insights about Lymphoma
Primary ICD-10-CM Codes for lymphoma
Decision Criteria
clinical Criteria
- DLBCL confirmed by biopsy
Applicable To
- DLBCL, nodal
Excludes
- Burkitt lymphoma (C83.7)
Clinical Validation Requirements
- Histopathological confirmation
- Immunohistochemistry results
Code-Specific Risks
- Misclassification if subtype is not specified
Coding Notes
- Ensure subtype is documented for accurate coding.
C83.3A - Diffuse large B-cell lymphoma, in remission
Use when DLBCL is in remission as confirmed by imaging.
Applicable To
- DLBCL in remission
Clinical Validation Requirements
- PET/CT showing Deauville score 1-3
- Clinical note stating 'no evidence of disease'
Coding Notes
Documentation must confirm remission status.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Burkitt lymphoma
C83.7Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Lymphoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C83.3.
Impact
Clinical: May affect treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential for claim denials.
Mitigation Strategy
Ensure pathology reports are complete, Include subtype in all documentation
Impact
Reimbursement: May lead to reduced reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of health records.
Mitigation Strategy
Ensure documentation specifies subtype and remission status.
Impact
Lack of documentation for remission status.
Mitigation Strategy
Ensure imaging results are included in patient records.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Lymphoma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Lymphoma
Use these documentation templates to ensure complete and accurate documentation for Lymphoma. These templates include all required elements for proper coding and billing.
Oncology progress note
Specialty: OncologyRequired Elements
- Diagnosis
- Treatment plan
- Imaging results
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Lymphoma? Ask your questions below.